Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
• Ex BBDA Legal Counsel GUILTY for tax crimes
(thanks to Integral for followup)
James RJ Scheltema heading to the klink!?
What an a__ getting his wife involved.
Pensacola attorney pleads to tax crimes
From staff reports , pnj.com Published 10:36 a.m. CT Jan. 20, 2017 | Updated 12:49 p.m. CT Jan. 20, 2017
A Pensacola attorney pleaded guilty on Friday to filing false tax returns and tax evasion.
James R.J. Scheltema, 56, is a certified public accountant and attorney. Between 2010-13, Scheltema received restricted stock as compensation for his legal and accounting services. He initially reported no compensation on his 2011-12 individual income tax returns, according to a release from the U.S. Attorney's Office, despite receiving substantial compensation from stock issuance and the sale of stock.
Scheltema also failed to file timely individual and corporate income tax returns for two companies he owned and operated, then tried to evade notice of stock sales by instructing checks be made payable to his wife and his companies rather than himself. After being notified of an IRS investigation, Scheltema filed amended 2011-12 returns and a delinquent 2013 return, which were also false, according to the report.
Scheltema faces a maximum of three years in prison for each charge of filing false returns, and a maximum of five years in prison for the tax evasion charge. His sentencing hearing is scheduled for April 10.
Of course it is going lower.
The $100M fine not a big deal, but the forced Synacthen drug competitor will completely wipe out all Acthar.
That's billions down the drain long-term.
Mallinckrodt (MNK) to Pay $100M to Settle FTC, State Charges for Violating Antitrust Laws
Mallinckrodt ARD Inc., (NYSE: MNK) formerly known as Questcor Pharmaceuticals, Inc., and its parent company, Mallinckrodt plc, have agreed to pay $100 million to settle Federal Trade Commission charges that they violated the antitrust laws when Questcor acquired the rights to a drug that threatened its monopoly in the U.S. market for adrenocorticotropic hormone (ACTH) drugs. Acthar is a specialty drug used as a treatment for infantile spasms, a rare seizure disorder afflicting infants, as well a drug of last resort used to treat other serious medical conditions.
The FTC’s complaint alleges that, while benefitting from an existing monopoly over the only U.S. ACTH drug, Acthar, Questcor illegally acquired the U.S. rights to develop a competing drug, Synacthen Depot. The acquisition stifled competition by preventing any other company from using the Synacthen assets to develop a synthetic ACTH drug, preserving Questcor’s monopoly and allowing it to maintain extremely high prices for Acthar.
“Questcor took advantage of its monopoly to repeatedly raise the price of Acthar, from $40 per vial in 2001 to more than $34,000 per vial today – an 85,000 percent increase,” said FTC Chairwoman Edith Ramirez. “We charge that, to maintain its monopoly pricing, it acquired the rights to its greatest competitive threat, a synthetic version of Acthar, to forestall future competition. This is precisely the kind of conduct the antitrust laws prohibit.”
Acthar is a specialty drug used as a treatment for infantile spasms, a rare seizure disorder afflicting infants, and a drug of last resort to treat several other serious medical conditions – including nephrotic syndrome, flare-ups of multiple sclerosis, and rheumatoid disorders. According to the complaint, Acthar treatment for an infant with infantile spasms can cost more than $100,000.
In Europe, Canada, and other parts of the world, the complaint notes that doctors treat patients suffering from these conditions with Synacthen Depot, which is available at a fraction of Acthar’s price in the United States. The complaint alleges that Questcor has consistently viewed Synacthen Depot as a significant competitive threat to its Acthar monopoly in the United States.
The FTC alleges that in June 2013, Questcor acquired the U.S. rights to Synacthen from Novartis AG, outbidding several other companies that were seeking to acquire the rights to Synacthen. Those alternative bidders were interested in developing the drug and had plans to sell it at a significant discount to Acthar’s price, capturing a substantial amount of Questcor’s business. The FTC charges that Questcor’s acquisition of Synacthen stifled competition and eliminated the possibility that an alternative bidder would make the drug available in the U.S. market and compete with Acthar.
In addition to the $100 million monetary payment, the proposed stipulated court order requires that Questcor grant a license to develop Synacthen Depot to treat infantile spasms and nephrotic syndrome to a licensee approved by the Commission.
A monitor will ensure that Questcor complies with its obligation to grant the license within 120 days of the entry of the order; after that time, a trustee will be appointed to effectuate the license. The order also requires Questcor to provide periodic reports on its efforts, and provide the Commission with advance notice of any future acquisitions of U.S. rights to ACTH drugs.
The states of Alaska, Maryland, New York, Texas and Washington joined in the FTC’s complaint. Under the settlement, the states will receive $10 million from the $100 million judgment and an additional $2 million as payment for attorney’s fees and costs.
The Commission vote authorizing staff to file the complaint and the proposed stipulated order in federal court was 3-0. Commissioner Maureen K. Ohlhausen issued a concurring statement. FTC staff filed the complaint and proposed order in the U.S. District Court for the District of Columbia.
NOTE: The Commission files a complaint when it has “reason to believe” that the law has been or is being violated and it appears to the Commission that a proceeding is in the public interest. Stipulated orders have the force of law when approved and signed by the District Court judge.
http://www.streetinsider.com/Corporate+News/Mallinckrodt+(MNK)+to+Pay+$100M+to+Settle+FTC,+State+Charges+-+Bloomberg/12436033.html
What a set up.
Someone just made a boat load of $$$. Quickest settlement ever.
"We are pleased to confirm that we have entered into a settlement agreement with the FTC staff to fully resolve this matter, subject to approval by the Commission. We will comment further at the appropriate time."
Hows the top 100 jerky list working out today?
Santa is not real kids.
Horrible managing products as well, has to give away beanies to sell product.
https://www.amazon.com/Jerky-Gourmet-Cured-Brisket-Camouflage/dp/B01MQRJK6J
So the product is 5 bags of jerky+hat.
On the right where you select the product to buy it shows "9 Flavors: Multi Pack Gift Set"
Under "About the Product" it only lists the 5 flavors that I'm assuming the customer receives.
Then in the product description down the page it displays:
"Featuring 8 ORIGINAL FLAVORS."
Apparently the seller removed 3 bags of jerky and replaced them with a cheap flashlight beanie... which of course notrealSanta sells the beanie on ebay for $9.
WOW WHAT A DEAL! HILARIOUS! Might as well package jerky with Christmas lights, LOL!
There are now 3MM on ask, no bid.
Of course you fail to mention the fact the suggested price for the retail stores...
Apparently buying a dealership doesn't protect you from other online HJOE dealers!
...HJOE jerky isn't popular on Amazon.
Thought we would see the 20's today
3rd party sellers used a trick to get on the Hot and New list.
Jack Links Teriyaki (and the other 5 flavors) is definitely not a new item, LOL! You should also have noticed that there are ZERO reviews for that particular product (out of the general 2600+).
That's why the Hot and New Releases list is bogus and everyone laughs at it.
Maggots being on that list proves it.
Nope, still trading.
Someone bought 1M today...for some reason.
No bid.
Amazon does a weird grouping of reviews.
Reviews of other products by that company can be listed as well. Sometimes there's a little data field noting what product that reviewer is talking about, but overall its too easy to get confused.
When viewing "all" verified purchase reviews, there is a filter to just list that product's reviews (if any).
So is there a problem that the company doesn't have their own seller account on Amazon?
Why is it going through an "outlet" store and products have no Prime option?
Normally it is the company themselves that are the first ones to sell their own product on Amazon and not a 3rd party.
The Amazon seller orders the amount he chooses to by the pallet just like all the dealers do.
What a mental case.
So there's a production problem.
Flavors shouldn't be sold out if they are "that popular".
There's a Historical tab.
example:
http://ih.advfn.com/stock-market/OTCBB/silversun-technologies-inc-SSNT/historical
Also appears near the bottom of quote page (under Latest Messages).
So the IPA Beer Jerky is faring worse than the Mixed Pupae?
IPA Beer is yuckier than maggots? Why is that?
#59 Mixed Pupae
https://www.amazon.com/gp/new-releases/grocery/371475011/ref=zg_bs_tab_t_bsnr#3
#73 IPA Beer Jerky
https://www.amazon.com/gp/new-releases/grocery/371475011/ref=zg_bs_tab_t_bsnr#4
BBDA - Inactive - Administratively Dissolved (Tax)
Unsurprisingly tax was not paid and thus...
https://wyobiz.wy.gov/Business/FilingDetails.aspx?eFNum=139156196253141251029028070039008175089079194136
Winners Lounge Facebook removed.
Only the cache remains:
https://webcache.googleusercontent.com/search?q=cache:IwEAZRRrmiwJ:https://www.facebook.com/CrazieOverStockofWilkes/photos/a.161675074209154.1073741828.161659164210745/173197263056935/%3Ftype%3D3+&cd=2&hl=en&ct=clnk&gl=us
Something happen to SWKTECH twitter?
Feels like a lot of the daily tweets were removed?
https://twitter.com/SWKTECH
Why not number 1?
What happened?
LOL! Amarillo Joes quickly removed CL listing.
http://amarillo.craigslist.org/bfs/5839123492.html
Page Not Found
like your link better its numbered but off to right under Hot New Releases HJ beef jerky is one of 3 shown out of 100 by viewing your link.
Why are all the certifications expired?
https://sunwinstevia.en.alibaba.com/company_profile.html
Ouch! That's why there are lawyers.
William G. Schulz
January 1 at 4:21pm
I have an investment in this company, a secured convertible debenture, and I would like to cash it and have my money back. However, the owner/manager does not respond to any of my inquireies and I have no idea what is happening with the company or the plans that I thought I was investing in. What's the deal here, Brian?
Kind of after-the-fact info.
Author talks of phase II data and eventually ends his idea with "There would be no need for phase III trials if the results of phase II trials were routinely regarded as definitive and practice changing."
Author is stating possible problems for future trials of whatever drug, hence "Future Challenges for Drug Development...". Perhaps forward looking to the many phase 2 studies that are ongoing:
http://www.exelixis.com/sites/default/files/pdf/Cabozantinib%20Clinical%20Trials%20-%20November%202016.pdf
Anyways, EXEL posted options news today? Seems they're looking long term.
GITOK LLC
https://www.sos.ok.gov/corp/corpInformation.aspx?id=3512556282
GITOK LLC
Details
Filing Number:
3512556282
Name Type:
Legal Name
Status:
In Existence
Corp type:
Domestic Limited Liability Company
Jurisdiction:
Oklahoma
Formation Date:
4 May 2016
Registered Agent Information
Name:
JERALD L. HALFORD
Effective:
4 May 2016
Address:
13541 W. 78TH STREET S.
City, State , ZipCode:
SAPULPA OK 74066 74066
Amarillo Joes still stuck?
Its been what, 2-3 months now and no buyers even with a huge discount? LOL! Maybe that's what the extra lawyers are for, to fight against the "dealers". Hilarious!
http://amarillo.craigslist.org/bfs/5839123492.html
I bought this business for $24,800 with Amarillo territory and now have to move out of the area for other career opportunities.
Dupe r/s info briefly appeared on otcmarkets
The other day a duplicate entry for the last R/S was presented on BBDA's OTCmarket listing and then later taken down:
http://www.otcmarkets.com/stock/BBDA/profile
Capital Change=shs decreased by 1 for 100 split. Pay date=12/18/2014.
http://ascopubs.org/doi/full/10.1200/JCO.2016.71.0673
..and the recent sell off of management shares.
Greedy lost their place in line.
Put back their huge millions holding back on ask .0001, can't get rid of it!
Now they gotta wait for others to empty first!
I don't need that list.
Cannot trust that new release list.
When the #13 best seller is moth poop tea!
HILARIOUS!
I guess Amazon thinks POOP = jerky!
Dey dun it twice.
There just were 3MMs on ask, now 2 after that boo-boo.
Sum dun goofed!
.0002 flipper got stuck and has to spend more commission $ trying to get out but really just screwing up the chart.
Ugly day today with no bad news that I am aware of
Wonder if Fletcher ratted Weber out?
Maybe why Weber didn't hire an attorney?
That'd be absolutely hilarious!